XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Cash flows from operating activities--    
Net earnings $ (314,670,000) $ 316,129,000
Adjustments to reconcile net earnings to net cash provided by operating activities--    
Depreciation and amortization expense 97,165,000 94,836,000
Non-cash share-based compensation 8,608,000 30,139,000
Deferred income taxes (32,228,000) 27,659,000
Net periodic pension benefit (4,653,000) (11,244,000)
Other Noncash Income (Expense) (132,000) 661,000
Changes in assets and liabilities, net of acquisitions    
Accounts receivable, net (1,146,000) 31,354,000
Inventories, net (32,946,000) 33,045,000
Prepaid expenses and other assets (26,654,000) (20,073,000)
Accounts payable 28,650,000 (13,706,000)
Accrued expenses and other liabilities 8,368,000 (41,718,000)
Net cash provided by operating activities 439,478,000 447,082,000
Cash flows from investing activities--    
Additions to property and equipment (74,917,000) (36,169,000)
Payments to Acquire Intangible Assets (1,114,000) (80,000)
Acquisitions, net of cash acquired (34,526,000) (7,750,000)
Net cash (used in) investing activities (110,557,000) (43,999,000)
Cash flows from financing activities--    
Proceeds under Credit Facility 865,500,000 0
Repayments under Credit Facility 449,264,000 21,875,000
Payment of principal upon maturity of Convertible Notes (744,527,000) 0
Net repayments under foreign bank loan (1,434,000) (1,611,000)
Payments of deferred purchase price (19,033,000) (3,878,000)
Repurchase of treasury stock (514,301,000) (18,258,000)
Payments of Debt Issuance Costs 3,167,000 0
Other, net 187,000 (167,000)
Net cash (used in) provided by financing activities (866,039,000) (45,789,000)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations 22,715,000 1,214,000
Changes in cash and cash equivalents--    
Net (decrease) increase in cash and cash equivalents (514,403,000) 358,508,000
Cash and cash equivalents at beginning of year 689,533,000 247,496,000
Cash and cash equivalents at end of quarter 175,130,000 606,004,000
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]    
Asset Impairment Charges $ 709,116,000 $ 0